Oral Oncology
Volume 38, Issue 3 , Pages 235-243 , April 2002

Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity

  • Satoru Shintani

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Ehime University School of Medicine, Ehime, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-89-960-5393; fax: +81-89-960-5396
    • ,
  • Mariko Mihara

      Affiliations

    • Department of Oral and Maxillofacial Surgery II, Okayama University Dental School, Okayama, Japan
    • ,
  • Yuji Nakahara

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Ehime University School of Medicine, Ehime, Japan
    • ,
  • Akihisa Kiyota

      Affiliations

    • Department of Oral and Maxillofacial Surgery II, Okayama University Dental School, Okayama, Japan
    • ,
  • Yoshiya Ueyama

      Affiliations

    • Department of Oral and Maxillofacial Surgery II, Okayama University Dental School, Okayama, Japan
    • ,
  • Tomohiro Matsumura

      Affiliations

    • Department of Oral and Maxillofacial Surgery II, Okayama University Dental School, Okayama, Japan
    • ,
  • David T.W Wong

      Affiliations

    • Laboratory of Molecular Pathology, Division of Oral Pathology, Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, Boston, USA

Received 22 February 2001 ,Accepted 29 March 2001.

References 

  1. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin- dependent kinases. Genes Dev. 1995;9:1149–1163
  2. Morgan DO. Principles of CDK regulation. Nature Lond. 1995;374:131–134
  3. Sherr CJ. Cancer cell cycle. Science. 1996;274:1672–1678
  4. Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY, et al.  Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J. 1995;9:1362–1370
  5. Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J, et al.  Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem. 1998;273:6704–6709
  6. Shintani S, Ohyama H, Zhang X, McBride J, et al.  p12DOC-1 is a novel CDK2-associated protein. Molecular and cellular Biology. 2000;20:6300–6307
  7. Schneeberger C, Eder S, Swoboda H, Ullrich R, Zeillinger R. A differential PCR system for the demonstration of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas. Oral Oncol. 1998;34:257–260
  8. Van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med. 1998;27:367–375
  9. Pande P, Mathur M, Shukla NK, Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol. 1998;34:396–403
  10. Kelman Z. PCNA (structure, function and interactions). Oncogene. 1997;14:629–640
  11. Waga S. Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 1994;369:574–578
  12. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, et al.  Proliferating cell nuclear antigen (PCNA) Immunolocalization In paraffin sections (an index of cell proliferation with evidence of deregulated expression In some neoplasms). J. Pathol. 1990;162:285–294
  13. Naggar A, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 1995;55:2656–2659
  14. WHO Collaborating Reference Centre for Oral Precancerous Lesions . Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. 1978;46:517–539
  15. Kusume T, Tsuda H, Kawabata M. Inoue T, Umesaki N, Suzuki T, et al. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer. Clin Cancer Res. 1999;5:4152–4157
  16. Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res. 1999;5:243–250
  17. Tsihlias J, Kapusta LR, DeBoer G, Morava Protzner I, Zbieranowski I, Bhattacharya N, et al.  Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res. 1998;58:542–548
  18. Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, Kohno Y, et al. Reduction of p12 DOC−1expression is a negative prognostic indication in head and neck/ oral cancer. Clin Cancer Res (in press).
  19. Xu J, Gimenez Conti IB, Cunningham JE, Collet AM, Luna MA, Lanfranchi HE, et al.  Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 1998;83:204–212
  20. Sartor M, Steingrimsdottir H. Elamin F, Glen J, Warnakulasuriya S, Partridge M, et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer. 1999;80:79–86
  21. Lonardo F, Rusch V, Langenfeld J, Dmitrovsky E, Klimstra DS. Overexpression of cuclin D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res. 1999;59:2470–2476
  22. Patel V, Jakus J, Harris CM, Ensley JF, Robbins KC, Yeudall WA. Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. Int J Cancer. 1997;73:551–555
  23. Kyomoto R, Kumazawa H, Toda Y. Sakaida N, Okumura A, Iwanga M, Shintaku M, et al. Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinom. Int. J Cancer. 1997;74:576–581
  24. Geradts J, Kratzke RA, Niehans GA, Lincoln CE. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/ Multiple Tumor Suppressor Gene 1 (CDK2/MTS1) product p16 ink4A in archival human solid tumors (Correlation with retinoblastoma protein expression). Cancer Res. 1995;55:6006–6011
  25. Reed A, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630–3633
  26. DiGiuseppe JA, Redston MS, Yeo CJ, Kern SE, Hruban RH. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol. 1995;147:884–888
  27. Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, et al.  Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cellcarcinoma. Cancer Lett. 2000;151(2):122–217

PII: S1368-8375(01)00048-3

Oral Oncology
Volume 38, Issue 3 , Pages 235-243 , April 2002

Article Tools

* Image Usage & Resolution